Does NILOTINIB Cause Glycosylated haemoglobin increased? 41 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Glycosylated haemoglobin increased have been filed in association with NILOTINIB (nilotinib). This represents 0.2% of all adverse event reports for NILOTINIB.
41
Reports of Glycosylated haemoglobin increased with NILOTINIB
0.2%
of all NILOTINIB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Glycosylated haemoglobin increased From NILOTINIB?
Of the 41 reports, 1 (2.4%) resulted in death, 11 (26.8%) required hospitalization, and 7 (17.1%) were considered life-threatening.
Is Glycosylated haemoglobin increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Glycosylated haemoglobin increased?
DULAGLUTIDE (2,691)
INSULIN GLARGINE (2,649)
INSULIN LISPRO (2,482)
METFORMIN (1,539)
INSULIN HUMAN (1,008)
EXENATIDE (921)
SEMAGLUTIDE (818)
EMPAGLIFLOZIN (743)
TIRZEPATIDE (555)
INSULIN ASPART (550)
Which NILOTINIB Alternatives Have Lower Glycosylated haemoglobin increased Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB